Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

about

No association between cyclosporine levels and dyslipidemia?Improving long-term outcomes after pediatric renal transplantation by addressing dyslipidemia.Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients.

P2860

Q37671119-48F8F4FE-FA57-4EE4-933E-F53AD4028D87 Q48330750-220538B6-D4FE-4BFF-B370-2D328755751C Q51287889-ACDCDC9F-C0BB-461A-8F36-F57BBA24421D

P2860

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

Item

http://www.wikidata.org/entity/Q38029808

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

@en

type

Item

label

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

@en

prefLabel

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

@en

P1476

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

@en

P2093

Geneva Weiglein

http://www.w3.org/2001/XMLSchema#string

Guido Filler

http://www.w3.org/2001/XMLSchema#string

Mireille Tina Gharib

http://www.w3.org/2001/XMLSchema#string

Shelley Casier

http://www.w3.org/2001/XMLSchema#string

P2860

Are all n-3 polyunsaturated fatty acids created equal?

A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels

Plant sterols, marine-derived omega-3 fatty acids and other functional ingredients: a new frontier for treating hyperlipidemia.

Designer milk.

Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.

Progress in pediatric kidney transplantation.

Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.

Challenges in pediatric transplantation: the impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies.

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.

A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study.

P304

835-839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-3046.2012.01772.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230572071

http://www.w3.org/2001/XMLSchema#string

P698

22835217

http://www.w3.org/2001/XMLSchema#string

P921

hyperlipidemia

fatty acid

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

about

P2860

P2860

Ω3 fatty acids may reduce hyperlipidemia in pediatric renal transplant recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921